Abstract Papillary thyroid cancer (PTC), the most prevalent form of thyroid malignancy, is generally indolent but poses a recurrence risk of 10%-15%, leading to a clinical paradox: the need to…
This article discusses the limitations of current clinicopathologic approaches to risk stratification in papillary thyroid cancer and introduces Thyroid GuidePx® as a molecular diagnostic tool to better predict recurrence risk.…
Abstract Cancer care through molecular diagnostics: Addressing papillary thyroid cancer Oliver Bathe from the University of Calgary and Qualisure Diagnostics, walks us through addressing the surge in papillary thyroid cancer…
Thyroid GuidePx® is now cited in the 2025 ATA Guidelines. This recognition highlights the growing role of molecular classifiers in papillary thyroid cancer — providing patient-specific recurrence risk to guide…
See the full Made in CA Interview with Dr. Oliver Bathe MD, FRCSC, FACSQualisure Diagnostics develops state-of-the-art diagnostic tests that help to personalize cancer care. Our first test, Thyroid GuidePx,…
The University of Calgary Department of Oncology and the Arnie Charbonneau Cancer Institute awarded $18,750 to Dr. Bathe and colleagues in endocrine surgery and pathology. The seed grant will be…
Qualisure Diagnostics Inc. and Protean BioDiagnostics Inc. together will perform the technical validation essential to launch Thyroid GuidePx™ as a Laboratory Developed Test in the United States. Protean BioDiagnostics is…
Qualisure Diagnostics Inc. and OncoHelix Inc. will collaborate to prepare Thyroid GuidePx™ for introduction to the clinic. OncoHelix’s expertise in next generation sequencing (NGS) and Precision Oncology will be leveraged…
Qualisure was awarded a $295,000 Alberta Innovates AICE-Validate grant to support further development of Thyroid GuidePx™, the next phase of the Molecular deCodeR build, and market access work. The AICE-Validate…
Qualisure Diagnostics Inc. researcher receives the Dr. Selwyn Taylor Award for best scientific presentation at the 48th World Congress of Surgery in Krakow, Poland Dr. Steven Craig, one of our…
